Topiramate

Product NDC
68382-358
11-digit product format
683820358
Labeler code
68382
Product ID
68382-358_2535bcc8-fac7-4b15-8c6f-fd6675655fd3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Topiramate
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Labeler
Zydus Pharmaceuticals USA Inc.
Application
ANDA207382
Marketing category
ANDA
Marketing start
2023-11-13
Substance
TOPIRAMATE
Active strength
200 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
0H73WJJ391TOPIRAMATE97240-79-4TOPIRAMATE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
68382-358-0168382035801100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-358-01) 2023-11-13NoNoHistorical
68382-358-0568382035805500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-358-05) 2023-11-13NoNoHistorical
68382-358-066838203580630 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-358-06) 2023-11-13NoNoHistorical
68382-358-78683820358783 BLISTER PACK in 1 CARTON (68382-358-78) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (68382-358-30) 3 blister pack2023-11-13NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
TopiramateZydus Pharmaceuticals USA Inc. | Zydus Worldwide DMCC | Zydus Lifesciences Limited2026-03-30HUMAN PRESCRIPTION DRUG LABEL10